%20CORP.%2C%20LTD./other/SHANGHAI_OBIO_TECHNOLOGY_GROUP_CORP.__QsWgeBs.png)
SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. — Investor Relations & Filings
SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. is a specialized Contract Development and Manufacturing Organization (CDMO) focused on the gene and cell therapy (GCT) sector. The company provides end-to-end solutions encompassing vector construction, process development, analytical method development, and large-scale GMP manufacturing. Its service portfolio includes the production of viral vectors such as adeno-associated virus (AAV), lentivirus, adenovirus, and oncolytic viruses, as well as plasmid DNA and cell therapy products. Obio Technology supports clients from early-stage research through clinical trials to commercialization. The company operates advanced facilities designed to meet international regulatory standards, facilitating the development of innovative genetic medicines and advanced therapies for global biopharmaceutical partners.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 独立董事关于第三届董事会第六次会议相关事项的事前认可意见 | 2023-04-19 | Chinese | |
| 《信息披露暂缓与豁免事务管理制度》 | 2023-04-19 | Chinese | |
| 《总经理工作细则》 | 2023-04-19 | Chinese | |
| 内控审计报告 | 2023-04-19 | Chinese | |
| 《独立董事工作细则》 | 2023-04-19 | Chinese | |
| 关于召开2022年度暨2023年第一季度业绩说明会的公告 | 2023-04-19 | Chinese |
Browse filings by year
5 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
15 filings
| |||||
| 40065164 | 独立董事关于第三届董事会第六次会议相关事项的事前认可意见 | 2023-04-19 | Chinese | ||
| 40065153 | 《信息披露暂缓与豁免事务管理制度》 | 2023-04-19 | Chinese | ||
| 40065141 | 《总经理工作细则》 | 2023-04-19 | Chinese | ||
| 40065125 | 内控审计报告 | 2023-04-19 | Chinese | ||
| 40065074 | 《独立董事工作细则》 | 2023-04-19 | Chinese | ||
| 40065072 | 关于召开2022年度暨2023年第一季度业绩说明会的公告 | 2023-04-19 | Chinese | ||
| 40065057 | 股东减持股份计划公告 | 2023-03-29 | Chinese | ||
| 40065046 | 股东减持股份计划公告 | 2023-03-29 | Chinese | ||
| 40065028 | 海通证券股份有限公司关于和元生物技术(上海)股份有限公司首次公开发行部分限售股上市流通的核查意见 | 2023-03-14 | Chinese | ||
| 40065016 | 关于首次公开发行部分限售股上市流通公告 | 2023-03-14 | Chinese | ||
| 40065008 | 2022年度业绩快报公告 | 2023-02-23 | Chinese | ||
| 40064999 | 关于为子公司提供担保的公告 | 2023-02-15 | Chinese | ||
| 40064986 | 和元智造(上海)基因技术有限公司财务报告(2022年1-9月) | 2023-02-15 | Chinese | ||
| 40064962 | 和元生物技术(上海)股份有限公司独立董事关于第三届董事会第五次会议相关事项的独立意见 | 2023-02-15 | Chinese | ||
| 40064956 | 海通证券股份有限公司关于和元生物技术(上海)股份有限公司为子公司提供担保的核查意见 | 2023-02-15 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58266/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58266 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58266 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58266 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58266}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. (id: 58266)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.